Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Thalassemia × Busulfan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 149 Leukemia 127 Myelodysplastic Syndromes 118 Precursor Cell Lymphoblastic Leukemia-Lymphoma 97 Lymphoma 88 Lymphoma, Non-Hodgkin 76 Multiple Myeloma 69 Hodgkin Disease 63 Leukemia, Lymphocytic, Chronic, B-Cell 58 Leukemia, Myeloid, Chronic-Phase 49 Myeloproliferative Disorders 48 Congenital Abnormalities 47 Lymphoma, Large B-Cell, Diffuse 46 Leukemia, Myelomonocytic, Chronic 46 Neoplasms, Plasma Cell 45 Leukemia, Myeloid, Accelerated Phase 45 Lymphoma, Follicular 41 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 41 Lymphoma, Mantle-Cell 38 Burkitt Lymphoma 38 Blast Crisis 37 Lymphoma, Large-Cell, Immunoblastic 35 Lymphoma, B-Cell, Marginal Zone 35 Anemia, Refractory, with Excess of Blasts 35 Primary Myelofibrosis 33 Recurrence 32 Myelodysplastic-Myeloproliferative Diseases 31 Hematologic Neoplasms 31 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 30 Graft vs Host Disease 30

Interventions

Cyclophosphamide 3 fludarabine phosphate 2 fludarabine 2 thymoglobulin 1 ruxolitinib 1 Whole-Body Irradiation 1 Tacrolimus 1 Rituximab 1 Peripheral Blood Stem Cell Transplantation 1 Panobinostat 1 Mycophenolic Acid 1 Mesna 1 Dexamethasone 1 Busulfan 1 Bortezomib 1 Alemtuzumab 1 AP 1903 reagent 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00578292 2020-05-01

THALLO

Baylor College of Medicine

Phase NA Terminated

10 enrolled 15 charts

Lymphoma, Follicular, Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡